Rxo (RXO) Other Accumulated Expenses (2021 - 2025)
Rxo's Other Accumulated Expenses history spans 5 years, with the latest figure at $10.0 million for Q4 2025.
- For Q4 2025, Other Accumulated Expenses fell 61.54% year-over-year to $10.0 million; the TTM value through Dec 2025 reached $10.0 million, down 61.54%, while the annual FY2025 figure was $10.0 million, 61.54% down from the prior year.
- Other Accumulated Expenses reached $10.0 million in Q4 2025 per RXO's latest filing, down from $12.0 million in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $26.0 million in Q4 2024 to a low of $5.0 million in Q3 2022.
- Average Other Accumulated Expenses over 5 years is $11.9 million, with a median of $12.0 million recorded in 2024.
- Peak YoY movement for Other Accumulated Expenses: skyrocketed 283.33% in 2024, then tumbled 61.54% in 2025.
- A 5-year view of Other Accumulated Expenses shows it stood at $6.0 million in 2021, then surged by 133.33% to $14.0 million in 2022, then fell by 7.14% to $13.0 million in 2023, then skyrocketed by 100.0% to $26.0 million in 2024, then crashed by 61.54% to $10.0 million in 2025.
- Per Business Quant, the three most recent readings for RXO's Other Accumulated Expenses are $10.0 million (Q4 2025), $12.0 million (Q3 2025), and $13.0 million (Q2 2025).